|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.851
|
Mouse |
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.657
|
Mouse |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.548
|
Mouse |
|
|
organelle assembly
|
GO:0070925 |
177 |
0.502
|
Mouse |
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.500
|
Mouse |
|
|
muscle contraction
|
GO:0006936 |
101 |
0.434
|
Mouse |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.433
|
Mouse |
|
|
muscle system process
|
GO:0003012 |
141 |
0.424
|
Mouse |
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.405
|
Mouse |
|
|
heart contraction
|
GO:0060047 |
93 |
0.383
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.345
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.335
|
Mouse |
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.298
|
Mouse |
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.295
|
Mouse |
|
|
digestive tract development
|
GO:0048565 |
190 |
0.289
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.284
|
Mouse |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.284
|
Mouse |
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.282
|
Mouse |
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.276
|
Mouse |
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.275
|
Mouse |
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.273
|
Mouse |
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.257
|
Mouse |
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.255
|
Mouse |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.253
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.246
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.243
|
Mouse |
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.226
|
Mouse |
|
|
actin filament organization
|
GO:0007015 |
113 |
0.220
|
Mouse |
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.210
|
Mouse |
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.202
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.200
|
Mouse |
|
|
circulatory system process
|
GO:0003013 |
197 |
0.195
|
Mouse |
|
|
cell adhesion
|
GO:0007155 |
329 |
0.190
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.190
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.188
|
Mouse |
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.181
|
Mouse |
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.156
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.155
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.154
|
Mouse |
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.144
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.144
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.132
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.126
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.126
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.122
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.119
|
Mouse |
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.115
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.115
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.114
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.113
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.111
|
Mouse |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.109
|
Mouse |
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.109
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.109
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.104
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.102
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.102
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.099
|
Mouse |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.098
|
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.095
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.094
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.086
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.085
|
Mouse |
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.084
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.083
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.080
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.079
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.074
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.074
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.074
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.074
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.071
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.071
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.068
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.068
|
Mouse |
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.067
|
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.066
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.064
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.063
|
Mouse |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.063
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.061
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.060
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.059
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.059
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.058
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.054
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.054
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.053
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.053
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.052
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.051
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.051
|
Mouse |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.051
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.050
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.050
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.048
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.048
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.048
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.048
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.047
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.047
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.046
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.046
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.046
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.045
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.045
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.045
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.045
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.044
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.044
|
|
|
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.044
|
Mouse |
|
|
germ cell development
|
GO:0007281 |
185 |
0.044
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.044
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.044
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.044
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.044
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.042
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.042
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.042
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.042
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.042
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.041
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.041
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.040
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.040
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.040
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.040
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.039
|
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.039
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.039
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.038
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.038
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.038
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.038
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.038
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.038
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.037
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.037
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.037
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.037
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.037
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.036
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.036
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.036
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.036
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.036
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.036
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.036
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.036
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.035
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.035
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.035
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.035
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.035
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.034
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.034
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.034
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.033
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.033
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.033
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.033
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.033
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.033
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.033
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.032
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.032
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.032
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.032
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.032
|
Mouse |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.031
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.031
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.031
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.031
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.031
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.031
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.031
|
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
13 |
0.031
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.030
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.030
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.030
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.029
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.029
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.029
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.029
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.029
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.029
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.028
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.028
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.028
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.028
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.028
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.028
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.028
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.027
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.027
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.027
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.027
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.027
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.027
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.027
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.027
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.027
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.026
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.026
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.026
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.026
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.026
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.026
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.025
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.025
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.025
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.025
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.025
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.024
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.024
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.024
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.024
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.024
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.024
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.024
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
negative regulation of endocytosis
|
GO:0045806 |
12 |
0.024
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.024
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.024
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.024
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.023
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.023
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.023
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.023
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.023
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.023
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.023
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.023
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.023
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.022
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.022
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.022
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.021
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.021
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.021
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.021
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.021
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.021
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.021
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.021
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.021
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.020
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.020
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.020
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.020
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.020
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.020
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.020
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.020
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.020
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.019
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.019
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.019
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.019
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.019
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.019
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.019
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.019
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.019
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.019
|
|
|
|
regulation of cell adhesion mediated by integrin
|
GO:0033628 |
13 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.019
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.019
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.018
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.018
|
Mouse |
|
|
response to metal ion
|
GO:0010038 |
47 |
0.018
|
|
|
|
alanine transport
|
GO:0032328 |
4 |
0.018
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.018
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.018
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.018
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.018
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.018
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.018
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.018
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.018
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.018
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.018
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.018
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.018
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.018
|
|
|
|
negative regulation of hepatocyte proliferation
|
GO:2000346 |
3 |
0.017
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.017
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.017
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.017
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.017
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.017
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.017
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.017
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.017
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.017
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.017
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.016
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.016
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.016
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.016
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.016
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.016
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.016
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.016
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.016
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.015
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.015
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.015
|
|
|
|
tubulin complex biogenesis
|
GO:0072668 |
2 |
0.015
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.015
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.015
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.015
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.015
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.015
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.015
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.015
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.015
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.015
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.015
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.015
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.015
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.015
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.015
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.015
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.015
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.015
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.014
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.014
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.014
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.014
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.014
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.014
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.014
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.014
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.014
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.014
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.014
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.014
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.014
|
|
|
|
positive regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030511 |
12 |
0.014
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.014
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.014
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.014
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.014
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.013
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.013
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.013
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.013
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.013
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.013
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.013
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.013
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.013
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.013
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.013
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.013
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.013
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.013
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.013
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.013
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.013
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.013
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.013
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.013
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.013
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.013
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.013
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.013
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.013
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.013
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.013
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.013
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.013
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.013
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.013
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.013
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.013
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.013
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.013
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.013
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.013
|
|
|
|
negative regulation of potassium ion transmembrane transporter activity
|
GO:1901017 |
3 |
0.013
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.013
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.013
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.013
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.013
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.013
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.012
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.012
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.012
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.012
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.012
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.012
|
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.012
|
|
|
|
negative regulation of t helper 2 cell differentiation
|
GO:0045629 |
4 |
0.012
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.012
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.012
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.012
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.012
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.012
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.012
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.012
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.012
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.012
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.012
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.012
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.012
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.012
|
|
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.012
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.012
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.012
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.012
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.012
|
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.012
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.012
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.012
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.012
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.012
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.011
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.011
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.011
|
|